Global Arthritis Monoclonal Antibodies Market Size To Exceed USD 129.65 Billion By 2035 | CAGR of 7.61%
Category: HealthcareGlobal Arthritis Monoclonal Antibodies Market Size To Exceed USD 129.65 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Arthritis Monoclonal Antibodies Market Size is expected to grow from USD 57.85 Billion in 2024 to USD 129.65 Billion by 2035, at a CAGR of 7.61% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the “Global Arthritis Monoclonal Antibodies Market Size, Share, and COVID-19 Impact Analysis, By Type (Humira, Remicade, Enbrel, Rituxan, and Others), By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/arthritis-monoclonal-antibodies-market
The arthritis monoclonal antibodies market refers to the industry for engineered protein drugs used for treating inflammatory arthritis conditions such as rheumatoid arthritis. Monoclonal antibody medications are used if other rheumatoid arthritis treatments aren’t effective, work by the principle of binding to an antigen protein on the surface of a cell, which helps in protecting from exposure. Increasing R&D efforts for discovering novel monoclonal antibodies are providing new market growth opportunities for arthritis monoclonal antibodies. The growing prevalence of autoimmune diseases and the advancement in biotechnology & genetic engineering are driving the market. However, an increased cost of monoclonal antibody therapies and strict regulations, along with intense competition among key players, are challenging the market.
The Humira segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the type, the arthritis monoclonal antibodies market is divided into Humira, Remicade, Enbrel, Rituxan, and others. Among these, the Humira segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Humira is a formulation of a fully human anti-TNF-α monoclonal antibody, which is a protein that plays a central role in the inflammatory response in autoimmune diseases, including arthritis.
The rheumatoid arthritis segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the arthritis monoclonal antibodies market is divided into rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others. Among these, the rheumatoid arthritis segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Adalimumab, infliximab, and rituximab are some of the drugs that aid in suppressing inflammation, improving symptoms, and slowing joint damage in rheumatoid arthritis.
North America is expected to hold the majority share of the global arthritis monoclonal antibodies market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global arthritis monoclonal antibodies market during the forecast period. The increasing prevalence of arthritis, especially among the aging population, along with the emergence of advanced therapies like mAbs, is driving the market. Substantial government investments in R&D, enhancing innovation and improving treatment options, are promoting market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global arthritis monoclonal antibodies market during the forecast period. The presence of a robust ecosystem for the adoption of cutting-edge biologics, in order to develop and utilize monoclonal antibodies, is driving the market for the arthritis monoclonal antibodies market.
Major vendors in the global arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc., AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC, Mylan N.V., Hoffmann-La Roche Ltd., Sanofi SA, Daiichi Sankyo Company Ltd., Eli Lilly and Company, Sigma-Aldrich Co. LLC, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2025, Zoetis Inc. announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) had adopted a positive opinion recommending the granting of marketing authorization for Portela (relfovetmab), a new monoclonal antibody therapy intended for the alleviation of pain associated with osteoarthritis (OA) in cats.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the arthritis monoclonal antibodies market based on the below-mentioned segments:
Global Arthritis Monoclonal Antibodies Market, By Type
- Humira
- Remicade
- Enbrel
- Rituxan
- Others
Global Arthritis Monoclonal Antibodies Market, By Application
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Fibromyalgia
- Others
Global Arthritis Monoclonal Antibodies Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?